600380.SSShanghai
Joincare Pharmaceutical Group Industry Co.,Ltd.
¥9.78
ListedJun 8, 2001
SectorHealthcare
IndustryDrug Manufacturers — Specialty & Generic
CountryChina
Employees13575
State-| CityShenzhen| AddressJoincare Pharmaceutical Group Building| Phone86 75 8625 2368
Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China and internationally. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and traditional Chinese medicine, including cold medicine anti-viral granules and anti-tumor medicine. It also provides diagnostic reagents and equipment, such as mycoplasma pneumoniae IgM antibody test and antinuclear antibody test kit; OTC products which includes Taitai and Jingxin oral liquid, Eagle's American ginseng tea, and YikeTie; and biologics comprising tocilizumab and mouse nerve growth factor injection. The company was founded in 1992 and is headquartered in Shenzhen, China.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
14.0
?
Div. Rate
¥0.20
?
Div. Yield
1.96%
?
Payout Ratio
27.40%
?
Max Consec. Div. Years
13 years
?
Longest Consec. Div.
13 years
?
Div. Coverage
83%
?
Div. Stability Rate
0.13
?
Div. Growth Rate
50.00%
?
Score
83

Dividend History

Historical dividend payments by ex-dividend date.

Jul 18, 2025
¥ 0.2000
Jul 18, 2024
¥ 0.1800
Jul 21, 2023
¥ 0.1800
Jun 30, 2022
¥ 0.1500
Jun 25, 2021
¥ 0.1500
Jul 3, 2020
¥ 0.1600
May 24, 2019
¥ 0.1600
Jul 4, 2018
¥ 0.1629
Aug 4, 2017
¥ 0.1448
Jul 6, 2016
¥ 0.0905
Aug 10, 2015
¥ 0.0905
Jul 10, 2014
¥ 0.0362
Jul 25, 2013
¥ 0.0362
Jun 8, 2009
¥ 0.0754
Apr 24, 2008
¥ 0.0349
May 25, 2006
¥ 0.0337
Jun 1, 2005
¥ 0.0278
May 20, 2004
¥ 0.0401
Jun 10, 2003
¥ 0.0492
Jun 3, 2002
¥ 0.0422
Sep 18, 2001
¥ 0.0281

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!